Is a GLP-1 Prescription HSA or FSA Eligible? Here's the Actual IRS Rule

A GLP-1 prescription running $300-$1,000+ a month before any discount is exactly the kind of expense worth running through pre-tax dollars if you can. Whether you can depends on IRS rules that are more specific than "any health-related expense counts" — and getting the framing wrong can mean a denied claim later. Here's the actual rule, not a paraphrase.

The IRS rule that governs this

IRS Publication 502, the governing document for what counts as a deductible medical expense (and by extension, what your HSA or FSA administrator will typically accept), draws a specific line on weight-loss treatment: "amounts you pay to lose weight if it is a treatment for a specific disease diagnosed by a physician (such as obesity, hypertension, or heart disease)" are includible medical expenses¹. The key phrase is "treatment for a specific disease diagnosed by a physician" — not "any expense that helps you lose weight." The same publication draws a related line for weight-loss programs generally, allowing "fees you pay for membership in a weight reduction group as well as fees for attendance at periodic meetings," while explicitly excluding "the cost of diet food or beverages in medical expenses because the diet food and beverages substitute for what is normally consumed to satisfy nutritional needs"¹ — a reminder that the IRS distinguishes treatment for a diagnosed condition from general lifestyle spending, even when both relate to weight.

How this applies to a GLP-1 prescription specifically

Publication 502 doesn't carry a line item naming Ozempic, Wegovy, or Zepbound directly, but the general rule for medicines is unambiguous: "you can include in medical expenses amounts you pay for prescribed medicines and drugs"¹. Put those two rules together and the practical takeaway is this: a GLP-1 prescribed by a physician to treat a diagnosed condition — obesity (typically documented via BMI and a formal diagnosis code), type 2 diabetes, or another condition the drug is FDA-approved to treat — fits squarely within what HSA and FSA plans are built to reimburse. A prescription written on that basis, with documentation from your prescriber, is generally treated the same as any other prescribed medication for HSA/FSA purposes.

What can complicate a claim

Two things are worth knowing before you assume reimbursement is automatic. First, some FSA and HSA plan administrators require a Letter of Medical Necessity for weight-management drugs specifically, even when the underlying IRS rule doesn't technically demand one for a standard prescription — this is a plan-level requirement, not a universal one, so check with your specific administrator rather than assuming. Second, if a GLP-1 is prescribed for a purpose the FDA hasn't approved it for (a use outside its labeled indications), that can complicate the "treatment for a specific disease" framing an administrator is looking for — another reason a documented, on-label diagnosis from your prescriber matters, not just a prescription.

Why this is worth doing even on top of insurance or cash-pay pricing

Because HSA and FSA contributions are pre-tax, running a GLP-1 expense through one effectively discounts the cost by your marginal tax rate — often 20-35% depending on your bracket, before any other savings mechanism. That stacks independently of a manufacturer savings card (which we cover in do GLP-1 savings cards actually lower the price?) and independently of finding the cheapest legitimate cash-pay program, covered in the cheapest legit way to start GLP-1. None of these savings levers substitute for the others — a genuinely thorough approach checks all of them, not just whichever one a program's marketing happens to mention.

What this doesn't cover

This isn't tax advice, and IRS rules on medical expense eligibility can change — always confirm with your specific plan administrator or a tax professional before assuming a given purchase qualifies, especially since some employer-sponsored FSA and HSA plans layer additional restrictions on top of the baseline IRS rule. It also doesn't address whether your health insurance covers a GLP-1 at all, a separate question from HSA/FSA eligibility — if you're on Medicare specifically, see the Medicare GLP-1 Bridge Program: what it actually covers in 2026 for that different, narrower coverage picture.

Where this fits your decision

Before you assume a GLP-1 is unaffordable, run the full stack: check whether your employer plan covers it, confirm your HSA/FSA eligibility with your administrator using a documented diagnosis, check for a manufacturer savings card, and compare verified cash-pay pricing if none of those apply. Compare current pricing on our semaglutide and tirzepatide price boards, and see how we weigh total cost in our Value Score methodology.

This piece sits in our research index alongside every other sourced explainer we publish — the trials, the compounding rules and the pricing mechanics, grouped by the question each one answers.